Are you or someone you know living with Prostate Cancer?.
If so, you may be interested in learning more about participating in the CONTACT-02 clinical trial for men who have advanced prostate cancer, called metastatic castration-resistant prostate cancer (mCRPC). This is a cancer that has spread beyond your prostate gland and hormone therapy is no longer effective in stopping or slowing the disease.
The first step is to talk to your doctor about whether you are eligible to participate.
If you are interested in participating in this trial, you will be evaluated by the clinical trial site staff to determine whether you are eligible. CONTACT-02 will enroll eligible men who have been diagnosed with mCRPC. In order to participate, there are requirements regarding which prior therapies you have received.
To learn more, visit CONTACT02Patients.com